Skip to search formSkip to main contentSkip to account menu

Bortezomib/Dexamethasone/Lenalidomide Regimen

Known as: RVD, VRD, Velcade/Revlimid/Dexamethasone 
A treatment regimen consisting of a combination of bortezomib, dexamethasone and lenalidomide.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Patch-clamping and cell image analysis techniques were used to study the expression of the volume-activated Cl(-) current, I(Cl… 
Highly Cited
2001
Highly Cited
2001
The cystic fibrosis transmembrane conductance regulator (CFTR) protein has the ability to function as both a chloride channel and… 
Highly Cited
1998
Highly Cited
1998
1 The swelling‐activated outwardly rectifying Cl− current (ICl(swell)) recorded in T84 human intestinal cells was completely… 
Highly Cited
1994
Highly Cited
1994
PURPOSE The authors identify the signaling pathways for the regulatory volume decrease (RVD) of nonpigmented ciliary epithelial… 
Highly Cited
1990
Highly Cited
1990
Isolated hepatocyte suspensions were exposed to hypotonic and hypertonic stresses and serial cell volume measurements were made… 
Highly Cited
1988
Highly Cited
1988
Regulatory volume decreased (RVD) in lymphocytes in response to hyptonically induced swelling is dependent on the membrane… 
Review
1988
Review
1988
This article reviews what is known about the volume regulatory responses of lymphocytes. We present a discussion of recent data…